(Q41663931)

6 October 2017

Safety profile of sustained-release bupropion in depression: results of three clinical trials (English)

1 reference

6 October 2017

Settle EC

1

1 reference

6 October 2017

Stahl SM

2

1 reference

6 October 2017

Batey SR

3

1 reference

6 October 2017

Johnston JA

4

1 reference

6 October 2017

Ascher JA

5

1 reference

6 October 2017

1 March 1999

1 reference

6 October 2017

Clinical Therapeutics

1 reference

6 October 2017

21

1 reference

6 October 2017

3

1 reference

6 October 2017

454-463

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

6 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988301-0

7 January 2021

The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988301-0

7 January 2021

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988301-0

7 January 2021

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988301-0

7 January 2021

10.1016/S0149-2918(00)88301-0

Identifiers

DOI

1 reference

6 October 2017

1 reference